Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:NVZMY
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $42.76
- 200 Day Moving Avg: $38.24
- 52 Week Range: $31.57 - $49.55
Sales & Book Value:
- Trailing P/E Ratio: 29.89
- Foreward P/E Ratio: 25.28
- P/E Growth: 23.69
- Annual Revenue: $2.09 billion
- Price / Sales: N/A
- Book Value: $5.40 per share
- Price / Book: 8.29
- Average Volume: 21,297 shs.
Frequently Asked Questions for Novozymes A/S - (NASDAQ:NVZMY)
What is Novozymes A/S -'s stock symbol?
Novozymes A/S - trades on the NASDAQ under the ticker symbol "NVZMY."
How were Novozymes A/S -'s earnings last quarter?
Novozymes A/S - (NASDAQ:NVZMY) released its quarterly earnings results on Wednesday, April, 26th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.36 by $0.01. The business earned $535.97 million during the quarter. View Novozymes A/S -'s Earnings History.
Where is Novozymes A/S -'s stock going? Where will Novozymes A/S -'s stock price be in 2017?
6 equities research analysts have issued 12-month price objectives for Novozymes A/S -'s shares. Their predictions range from $47.50 to $47.50. On average, they anticipate Novozymes A/S -'s stock price to reach $47.50 in the next twelve months. View Analyst Ratings for Novozymes A/S -.
Who are some of Novozymes A/S -'s key competitors?
Some companies that are related to Novozymes A/S - include Fiserv (FISV), Ryanair Holdings plc (RYAAY), Western Digital Corp (WDC), Illumina (ILMN), Analog Devices (ADI), Lam Research (LRCX), Repsol SA (REPYY), Autodesk (ADSK), Infineon Technologies AG (IFNNY), Sirius XM Holdings (SIRI), Ross Stores (ROST), Spark New Zealand Ltd (SPKKY), American Airlines Group (AAL), Tokyo Electron (TOELY), Henderson Land Development (HLDCY), Telefonaktiebolaget LM Ericsson (ERIC), O'Reilly Automotive (ORLY) and EDF (ECIFY).
How do I buy Novozymes A/S - stock?
Shares of Novozymes A/S - can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Novozymes A/S - stock cost?
One share of Novozymes A/S - stock can currently be purchased for approximately $44.75.
Earnings History for Novozymes A/S - (NASDAQ:NVZMY)Earnings History by Quarter for Novozymes A/S - (NASDAQ:NVZMY)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Novozymes A/S - (NASDAQ:NVZMY)
Current Year EPS Consensus Estimate: $1.61 EPS
Next Year EPS Consensus Estimate: $1.77 EPS
Dividend History for Novozymes A/S - (NASDAQ:NVZMY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Novozymes A/S - (NASDAQ:NVZMY)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Novozymes A/S - (NASDAQ:NVZMY)
Latest Headlines for Novozymes A/S - (NASDAQ:NVZMY)
Novozymes A/S - (NVZMY) Chart for Sunday, May, 28, 2017